NUP98 and acute myeloid leukemia: KDM5A is the most common fusion partner of NUP98 in AML and AMKL (de Rooij et al., 2017; Cardin et al., 2019), and NSD1 (nuclear receptor) is the second most common (Mercher and Schwaller, 2019).